Conquering the barriers: are antibody therapeutics feasible for CNS indications?

From National Research Council Canada

DOIResolve DOI:
AuthorSearch for: 1; Search for: 1
Name affiliation
  1. National Research Council of Canada. Human Health Therapeutics
FormatText, Article
SubjectCNS therapeutics; blood–brain barrier; drug development
Publication date
Peer reviewedYes
NRC numberNRC-HHT-53292
NPARC number21275231
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifieref1e9ba6-ccdc-43dd-85d7-b5bc0110d90f
Record created2015-05-26
Record modified2020-04-22
Date modified: